関連する実験動画
Updated: Sep 9, 2025

11:19
Robotic Myotomy and Partial Fundoplication for Achalasia
Published on: August 11, 2023
1.6K
常見の食道運動障害における口腔内視鏡筋切除後の周立方体の変化
Siddarth Vyas1,2,3, Marc A Ward1,4,5, Brittany Buckmaster1,4
1Department of Minimally Invasive Surgery, Baylor University Medical Center, 3500 Gaston Ave, Dallas, TX, USA.
Surgical endoscopy
|August 28, 2025
まとめ
経口内視鏡筋切除 (POEM) は,いくつかのアハラシアのタイプで周回静止を回復しますが,他のタイプではそれを減少させることができます. POEM後のマノメトリーは,アハラシアサブタイプ,ジャックハンマー食道,食道関節流出阻害のさまざまな結果を明らかにします.
科学分野:
- 胃腸内科
- 内視鏡手術
- 食道運動障害
背景:
- 経口内視鏡筋切除 (POEM) は,アハラシアやその他の食道運動障害の治療法である.
- POEM後の食道体とLESのマノメトリックの変化は完全に理解されていません.
- この研究では,アカラシア型,ジャックハンマー食道,EGJIOのPOEM前後のマノメトリック機能が評価されます.
研究 の 目的:
- POEM後の食道体と LESのマノメトリックの変化を検査する.
- 様々な食道運動障害において,POEMの周立体および他のマノメトリックパラメータへの影響を評価する.
- タイプ1,2,3のアカラシア,ジャックハンマー食道,食道関節流出阻害のPOEM結果を比較する.
主な方法:
- IRBが承認した将来的に維持されるデータベースの遡及的レビュー.
- 術前と術後の高解像度マノメトリーを受けた患者を含む.
- 周立体および他のマノメトリックの発見を含む主要なエンドポイントの分析.
主要な成果:
- 265人の患者は入門基準を満たし,1型アカラシアの回復率は45. 5%であった.
- 2型アハラシアでは周立力が改善 (46. 8% から 60. 3%) 3型アハラシアでは周立力が低下 (82. 5% から 64. 5%)
- EGJIOは,POEM後のDCIと波幅の低下を示した.
結論:
- POEMは様々なアハラシア型および非アハラシア型疾患に有効です.
- 1型と2型アカラシアではペリスタルシスが回復しますが,タイプ3では失われます.
- EGJIOはPOEM後の最悪の結果を示し,周立体,DCI,波幅の低下を示しています.
関連する概念動画
Gastrointestinal Motility Disorders
593
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
593
Gastric Motility
1.2K
Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
1.2K
Barrett Esophagus-II: Clinical Manifestations and Management
292
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
292
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
395
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
395
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
593
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
593
Gastroesophageal Reflux Disease II: Clinical Features and Management
156
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
156

